Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News on Pharma

King's Award for export success through Covid for pharma packaging firm launched in Grimsby

ALLpaQ recognised for outstanding international trade after role in US vaccine roll-out

Birmingham Post

AstraZeneca overtakes Pfizer as crunch week for UK pharma looms

Driven by a revamped drug portfolio, AstraZeneca is expected to report revenues of $10.7bn in its latest quarterly results

The Guardian - UK

Canada will try to offer abortion drug mifepristone to American women if it’s banned in the US

Canada’s Families Minister Karina Gould reacted to the US legal battle over mifepristone the day before the US Supreme Court ruling

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

US Supreme Court keeps abortion pill fully available for now

WASHINGTON — The U.S. Supreme Court blocked a Texas judge’s restrictions on a widely used abortion pill from taking effect, keeping the drug fully available while a legal fight goes forward.

Tribune News Service

US supreme court blocks ruling limiting access to abortion pill

Federal judge in Texas ruled in early April to suspend FDA-approved mifepristone used in more than half of abortions in US

The Guardian - US

2 Healthcare Stocks Showing Stability With A and B POWR Ratings

The healthcare industry should thrive with accelerated breakthrough developments and a growing market for telemedicine and personalized medicines. Moreover, given the lingering macroeconomic headwinds, fundamentally strong healthcare stocks, Amgen (AMGN), and Otsuka Holdings (OTSKY) showing Stability with A and B POWR Ratings could be ideal buys. Read more.

StockNews.com

Top 3 Stocks to Sell in April With Weak Fundamentals

The biopharmaceutical industry has been grappling with various challenges, including inflation, the Fed’s hawkish stance, and new regulatory concerns. Hence, it could be wise to avoid Syndax Pharmaceuticals (SNDX), Senseonics Holdings (SENS), and Sio Gene Therapies (SIOX) due to their bleak fundamentals. Keep reading….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Stay Away From These 3 Stocks With Bearish Momentum in April

Coupled with fears about an economic downturn, several other headwinds could keep the biotechnology industry under significant pressure. Given this backdrop, fundamentally weak biotech stocks Day One Biopharmaceuticals (DAWN), Northwest Biotherapeutics (NWBO), and Ocugen (OCGN), with bearish momentum, could be avoided in April. Read on….

StockNews.com

Supreme Court delays decision in abortion drug case

WASHINGTON — The Supreme Court gave itself more time on a decision expected Wednesday about a commonly used abortion drug, extending until Friday a temporary pause on a lower court ruling that would restrict availability of mifepristone.

Tribune News Service

Generic abortion pill maker sues FDA to protect access

A generic-mifepristone maker sued the U.S. Food and Drug Administration to protect access to the medical abortion pill amid a welter of litigation stretching from Texas to Washington.

Tribune News Service

Supreme Court temporarily extends access to abortion pill

The court has given itself until Friday to rule on whether to allow restrictions to take effect on mifepristone as legal challenges to its FDA approval continue.

Chicago Sun-Times

Generic abortion pill manufacturer sues FDA in effort to preserve access

GenBioPro, which makes a generic form of mifepristone, is suing the FDA seeking to preserve access to the drug amidst ongoing federal litigation.

WEKU

Trade unions to urge Labour to make manifesto commitment to devolving drug law

TRADE Unions have agreed to urge Labour to include a commitment to devolve drug powers to Scotland in their next General Election manifesto.

The National (Scotland)

The drug company that prospered without creating any drugs

The new drug looked so promising — except for that one warning sign.

Tribune News Service

Get all your
news in one place.

100’s of premium titles.
One news app.

Tribune News Service

Abortion foes urge Supreme Court to curb pill on eve of deadline

Abortion opponents urged the U.S. Supreme Court to allow new restrictions on a widely used pill to end pregnancy, presenting the justices with a stark choice on one of the country’s most divisive issues.

StockNews.com

Why Insiders Are Aggressively Buying This Under $1 Stock

While insiders are showing significant interest in penny stock Processa Pharmaceuticals (PCSA), the stock has witnessed a weak momentum over the past year. Let’s take a look at its key metrics to understand if there is any hope for sustainable share price appreciation. Read on.

Al Jazeera

Anti-abortion groups urge US top court to restrict abortion pill

Groups push the US Supreme Court to reject Biden administration request to halt a Texas ruling limiting access to pill.

The Independent UK

Abortion foes urge justices to allow limits on abortion drug

Lawyers for anti-abortion doctors are urging the Supreme Court to allow restrictions to take effect on a drug used in the most common method of abortion in the United States, while a lawsuit continues

Get all your
news in one place.

100’s of premium titles.
One news app.

Daily Mirror

Tesco to close eight in-store pharmacies this year as part of huge shake-up

Tesco announced in January that was to introduce a raft of changes to the business in order to “remain focused and competitive in a fast-changing market”

The Guardian - US

Conservatives love judicial activism – as long as the law is moved in their favor

Brazen judicial overreach to curb abortion access proves the right wing will abandon their principles to get their way

Axios

Supreme Court blocks lower court rulings restricting abortion pills

The court's decision comes less than a year after it overturned Roe v. Wade, arguing it did not have the power to create abortion policy.

The Guardian - US

Biden administration asks US supreme court to halt abortion pill restrictions

Limits slated to go into effect at 12.01am Saturday following lower court’s order revoking the FDA’s approval of mifepristone

Tribune News Service

DOJ, drugmaker ask SCOTUS to intervene in abortion drug case

WASHINGTON — The Justice Department and a pharmaceutical company on Friday asked the Supreme Court to intervene in the court fight over a commonly used abortion drug in order to keep a court ruling restricting availability of the drug from taking effect this weekend.

Reuters

Abortion pill could be unavailable for months without Supreme Court action-U.S. DOJ

New court-imposed restrictions on the abortion pill mifepristone could cut off access to the drug entirely for months, the Biden administration and the drug's distributor, Danco Laboratories, said in petitions asking the U.S. Supreme Court to lift the curbs.

Tribune News Service

Commentary: Abortion pill ruling means more painful, later terminations

The conservative 5th Circuit has blocked part of a Texas judge’s decision to pull abortion drug mifepristone off the market, but leaves in place onerous and outdated restrictions that the Food and Drug Administration determined in 2016 were medically unnecessary.

1 … 51 52 53 54

People

Sristi Suman JayaswalThe

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Scottish Government

the Justice Department

the Food and Drug Administration

196 stories

the London Stock Exchange

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.